Derek L. Clouthier

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study).

A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study).

Journal: Journal of gastrointestinal oncology

Published: September 17, 2024

Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient.

Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient.

Journal: Nature communications

Published: April 12, 2023

Real-world treatment patterns and survival outcomes for treated biliary tract cancer patients using administrative databases in Ontario.

Real-world treatment patterns and survival outcomes for treated biliary tract cancer patients using administrative databases in Ontario.

Journal: Journal of gastrointestinal oncology

Published: February 23, 2023

A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 - 2018.

A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 - 2018.

Journal: Urologic oncology

Published: July 06, 2022

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.

Journal: Canadian liver journal

Published: January 12, 2022

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.

Journal: Nature communications

Published: October 09, 2020

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab.

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab.

Journal: Nature cancer

Published: March 07, 2020

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

Journal: Journal for immunotherapy of cancer

Published: December 18, 2018

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.

Journal: Genome medicine

Published: August 20, 2018

Costimulation, a surprising connection for immunotherapy.

Costimulation, a surprising connection for immunotherapy.

Journal: Science (New York, N.Y.)

Published: April 01, 2017

Dichotomous Expression of TNF Superfamily Ligands on Antigen-Presenting Cells Controls Post-priming Anti-viral CD4+ T Cell Immunity.

Dichotomous Expression of TNF Superfamily Ligands on Antigen-Presenting Cells Controls Post-priming Anti-viral CD4+ T Cell Immunity.

Journal: Immunity

Published: November 23, 2016

The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.

The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.

Journal: Nature immunology

Published: August 12, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026